Jean Benard
Overview
Explore the profile of Jean Benard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
64
Citations
1162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ambros I, Tonini G, Potschger U, Gross N, Mosseri V, Beiske K, et al.
J Clin Oncol
. 2020 Sep;
38(31):3685-3697.
PMID: 32903140
Purpose: For localized, resectable neuroblastoma without amplification, surgery only is recommended even if incomplete. However, it is not known whether the genomic background of these tumors may influence outcome. Patients...
2.
Festari M, Trajtenberg F, Berois N, Pantano S, Revoredo L, Kong Y, et al.
Glycobiology
. 2016 Dec;
27(2):140-153.
PMID: 27913570
Polypeptide GalNAc-transferases (GalNAc-Ts) constitute a family of 20 human glycosyltransferases (comprising 9 subfamilies), which initiate mucin-type O-glycosylation. The O-glycoproteome is thought to be differentially regulated via the different substrate specificities...
3.
Masserot C, Liu Q, Nguyen E, Gattolliat C, Valteau-Couanet D, Benard J, et al.
Mol Oncol
. 2015 Oct;
10(2):240-52.
PMID: 26482175
Neuroblastoma (NB) is the most common extra cranial solid tumor in childhood and the most frequently diagnosed neoplasm during infancy. A striking feature of this tumor is its clinical heterogeneity....
4.
Selmi A, de Saint-Jean M, Jallas A, Garin E, Hogarty M, Benard J, et al.
Cancer Lett
. 2014 Dec;
357(1):412-418.
PMID: 25475555
In neuroblastoma, MYCN amplification is associated with a worse prognosis and is a criterion used in the clinic to provide intensive treatments to children even with localized disease. In correlation...
5.
Gibert B, Delloye-Bourgeois C, Gattolliat C, Meurette O, Le Guernevel S, Fombonne J, et al.
J Natl Cancer Inst
. 2014 Oct;
106(11).
PMID: 25313246
Background: The Sonic Hedgehog (SHH) signaling pathway plays an important role in neural crest cell fate during embryonic development and has been implicated in the progression of multiple cancers that...
6.
Oberthuer A, Juraeva D, Hero B, Volland R, Sterz C, Schmidt R, et al.
Clin Cancer Res
. 2014 Sep;
21(8):1904-15.
PMID: 25231397
Purpose: To optimize neuroblastoma treatment stratification, we aimed at developing a novel risk estimation system by integrating gene expression-based classification and established prognostic markers. Experimental Design: Gene expression profiles were...
7.
Gattolliat C, Le Teuff G, Combaret V, Mussard E, Valteau-Couanet D, Busson P, et al.
Cancer Med
. 2014 Jun;
3(4):998-1009.
PMID: 24931722
Age at diagnosis, stage, and MYCN amplification are the cornerstones of the risk-stratification score of neuroblastoma that enables defining patients at low- and high risk. Refinement of this stratification is...
8.
9.
Bauer M, Benard J, Gaasterland T, Willert K, Cappellen D
PLoS One
. 2013 Nov;
8(11):e80526.
PMID: 24260410
WNT5A, a member of the WNT family of secreted lipid-modified glycoproteins, is a critical regulator of a host of developmental processes, including limb formation, lung morphogenesis, intestinal elongation and mammary...
10.
Benard J, Larsen C
Bull Cancer
. 2013 Jun;
100(7-8):697-713.
PMID: 23747694
The second half of the 20th century has been dominated by genetic models of tumors that provided conceptual tools explaining tumor genesis and its evolution. Other domains--epigenetics, cell metabolism--appeared that...